A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI

David Adlam, Maciej Zarebinski, Neal G. Uren, Pawel Ptaszynski, Keith G. Oldroyd, Shahzad Munir, Azfar Zaman, Hussain Contractor, Róbert Gábor Kiss, István Édes, Joanna Szachniewicz, Gergely Gyorgy Nagy, Mario J. Garcia, János Tomcsanyi, John Irving, Andrew S. P. Sharp, Piotr Musialek, Géza Lupkovics, Cheerag Shirodaria, Joseph B. SelvanayagamPauline Quinn, Leong Ng, Mark Roth, Michael A. Insko, Ben Haber, Stephen Hill, Lori Siegel, Simon Tulloch, Keith M. Channon (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI'. Together they form a unique fingerprint.

    Medicine & Life Sciences